Charles B Epstein

Dana-Farber Cancer Inst

$2,898,941

Attributed

$2,898,941

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $488.4K · FY2017–25

$500K$375K$250K$125K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,898,941 · 2

By mechanism

P01$2,898,941 · 2

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Laurie H Glimcher$56,303,115
Franziska Michor$16,040,992
Giovanni Parmigiani$15,786,814
David S Pellman$18,057,380
Herve Avet Loiseau$3,475,894

Others in their field

Other Emerging Leaders on “Multiple Myeloma”

Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
Geoffrey Roger Hill · Fred Hutchinson Cancer Center$6,010,647
Gareth John Morgan · Tezcat Laboratories Llc$5,963,595
Kimberly A. Bertrand · Boston University Medical Campus$5,843,599
Paul M Barr · University Of Rochester$5,073,440

Research focus

Multiple MyelomaNeoplastic CellMapsMolecularMissionCell CountHistone ModificationInnovationChromatinChromatin StructureClinical TrialsCancer GenomicsCofactorDiagnosisCellsAdoptedChip-SeqEpigenetic ProcessEpigenomicsGene ExpressionGene Expression RegulationGenetic Enhancer ElementGenomicsNew Therapeutic Target